ZwickRoell
ZwickRoell, a global leader in materials testing technology, has announced a new strategic partnership with Cormica MET, an FDA-compliant testing laboratory. This collaboration aims to provide early-stage development companies with seamless access to advanced testing services and regulatory guidance, significantly enhancing their ability to achieve proof of concept for innovative medical technologies.
As part of this partnership, ZwickRoell will connect its customers, particularly those in the initial phases of product development, to Cormica MET's expertise and FDA-compliant testing capabilities. The companies say this collaboration is designed to streamline the testing process, helping clients accelerate their journey from concept to market while ensuring compliance with regulatory standards.
"We are excited to partner with Cormica MET, a respected name in the field of medical device testing," said Lee White, UK Sales & Marketing Manager, ZwickRoell. "This partnership will enable our customers to access critical testing services and guidance that can be a game-changer for early-stage companies looking to validate their innovations effectively."
Cormica MET brings extensive experience in providing rigorous testing and regulatory support tailored to the medical device industry. Their FDA-compliant laboratory services will now be readily accessible to ZwickRoell customers, allowing for efficient and effective proof of concept evaluations.
"We look forward to working closely with ZwickRoell to support innovators in the medical technology space," said Angela Bell, General Manager, Cormica MET. "Together, we can offer a comprehensive solution that not only facilitates the testing process but also empowers our clients to navigate the complexities of regulatory compliance."
This partnership represents a significant step forward in ZwickRoell’s commitment to supporting the medical technology sector. By combining the strengths of both organisations, customers will benefit from a streamlined pathway to validation and market readiness.
